Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
34.90
-0.88 (-2.46%)
Aug 11, 2026, 10:09 AM EDT - Market open
Roivant Sciences Market Cap
Roivant Sciences has a market cap or net worth of $25.21 billion as of August 11, 2026. Its market cap has increased by 221.46% in one year.
Market Cap
25.21B
Enterprise Value
21.47B
1-Year Change
221.46%
Ranking
Category
Stock Price
$34.90
ChartMarket Cap Chart
Since December 8, 2020, Roivant Sciences's market cap has increased from $533.38M to $25.21B, an increase of 4,626.32%. That is a compound annual growth rate of 97.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 25.21B | 67.03% |
| Dec 31, 2025 | 15.09B | 75.25% |
| Dec 31, 2024 | 8.61B | -4.61% |
| Dec 29, 2023 | 9.03B | 55.76% |
| Dec 30, 2022 | 5.80B | -18.13% |
| Dec 31, 2021 | 7.08B | 1,257.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 40.62B |
| Royalty Pharma | 33.14B |
| Alnylam Pharmaceuticals | 29.30B |
| Insmed | 29.02B |
| Incyte | 24.75B |
| Moderna | 24.02B |
| BioNTech SE | 23.57B |
| Genmab | 18.45B |